{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T03:37:55Z","timestamp":1791085075041,"version":"4.1.0"},"publisher-location":"Dordrecht","reference-count":44,"publisher":"Springer Netherlands","isbn-type":[{"value":"9789400773585","type":"print"},{"value":"9789400773592","type":"electronic"}],"license":[{"start":{"date-parts":[[2013,9,17]],"date-time":"2013-09-17T00:00:00Z","timestamp":1379376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2013,9,17]],"date-time":"2013-09-17T00:00:00Z","timestamp":1379376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014]]},"DOI":"10.1007\/978-94-007-7359-2_17","type":"book-chapter","created":{"date-parts":[[2013,10,21]],"date-time":"2013-10-21T11:49:24Z","timestamp":1382356164000},"page":"349-359","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":131,"title":["Glaucoma and the Applications of Carbonic Anhydrase Inhibitors"],"prefix":"10.1007","author":[{"given":"Andrea","family":"Scozzafava","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,9,17]]},"reference":[{"key":"17_CR1","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/S0140-6736(10)61423-7","volume":"377","author":"HA Quigley","year":"2011","unstructured":"Quigley HA (2011) Glaucoma. Lancet 377:1367\u20131377","journal-title":"Lancet"},{"key":"17_CR2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1136\/bjo.2005.081224","volume":"90","author":"HA Quigley","year":"2006","unstructured":"Quigley HA, Broman AT (2006) The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 90:151\u2013156","journal-title":"Br J Ophthalmol"},{"key":"17_CR3","first-page":"243","volume-title":"Carbonic anhydrase \u2013 its inhibitors and activators","author":"F Mincione","year":"2004","unstructured":"Mincione F, Menabuoni L, Supuran CT (2004) Clinical applications of the carbonic anhydrase inhibitors in ophthalmology. In: Supuran CT, Scozzafava A, Conway J (eds) Carbonic anhydrase \u2013 its inhibitors and activators. CRC Press, Boca Raton, pp 243\u2013254"},{"key":"17_CR4","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/9780470508169.ch5","volume-title":"Drug design of zinc-enzyme inhibitors: functional, structural, and disease applications","author":"F Mincione","year":"2009","unstructured":"Mincione F, Scozzafava A, Supuran CT (2009) Antiglaucoma carbonic anhydrase inhibitors as ophthalomologic drugs. In: Supuran CT, Winum JY (eds) Drug design of zinc-enzyme inhibitors: functional, structural, and disease applications. Wiley, Hoboken, pp 139\u2013154"},{"key":"17_CR5","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1517\/13543776.2012.649006","volume":"22","author":"F Carta","year":"2012","unstructured":"Carta F, Supuran CT, Scozzafava A (2012) Novel therapies for glaucoma: a patent review 2007\u20132011. Expert Opin Ther Pat 22:79\u201388","journal-title":"Expert Opin Ther Pat"},{"key":"17_CR6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0002-9394(14)78354-0","volume":"32","author":"JS Friedenwald","year":"1949","unstructured":"Friedenwald JS (1949) The formation of the intraocular fluid. Am J Ophthalmol 32:9\u201327","journal-title":"Am J Ophthalmol"},{"key":"17_CR7","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1001\/archopht.1953.00920030409001","volume":"50","author":"VE Kinsey","year":"1953","unstructured":"Kinsey VE (1953) Comparative chemistry of of aqueous humor in posterior and anterior chambers of rabbit eye. Arch Ophthalmol 50:401\u2013417","journal-title":"Arch Ophthalmol"},{"key":"17_CR8","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0002-9394(14)78372-2","volume":"32","author":"VE Kinsey","year":"1949","unstructured":"Kinsey VE, Barany E (1949) The rate flow of aqueous humor. II. Derivation of rate of flow and its physiologic significance. Am J Ophthalmol 32:189\u2013202","journal-title":"Am J Ophthalmol"},{"key":"17_CR9","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/j.1748-1716.1951.tb00833.x","volume":"24","author":"PJ Wistrand","year":"1951","unstructured":"Wistrand PJ (1951) Carbonic anhydrase in the anterior uvea of the rabbit. Acta Physiol Scand 24:144\u2013148","journal-title":"Acta Physiol Scand"},{"key":"17_CR10","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0002-9394(55)90022-2","volume":"39","author":"B Becker","year":"1955","unstructured":"Becker B (1955) The mechanism of the fall in intraocular pressure by the carbonic anhydrase inhibitor Diamox. Am J Ophthalmol 39:177\u2013183","journal-title":"Am J Ophthalmol"},{"key":"17_CR11","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1001\/archopht.1959.04220010082009","volume":"62","author":"VE Kinsey","year":"1959","unstructured":"Kinsey VE, Reddy DVN (1959) Turnover of total carbon dioxide in aqueous humors and the effect thereon of acetazolamide. Arch Ophthalmol 62:78\u201383","journal-title":"Arch Ophthalmol"},{"key":"17_CR12","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1517\/13543776.10.5.575","volume":"10","author":"CT Supuran","year":"2000","unstructured":"Supuran CT, Scozzafava A (2000) Carbonic anhydrase inhibitors and their therapeutic potential. Expert Opin Ther Pat 10:575\u2013600","journal-title":"Expert Opin Ther Pat"},{"key":"17_CR13","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nrd2467","volume":"7","author":"CT Supuran","year":"2008","unstructured":"Supuran CT (2008) Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nature Rev Drug Discov 7:168\u2013181","journal-title":"Nature Rev Drug Discov"},{"key":"17_CR14","doi-asserted-by":"publisher","first-page":"3467","DOI":"10.1016\/j.bmcl.2010.05.009","volume":"20","author":"CT Supuran","year":"2010","unstructured":"Supuran CT (2010) Carbonic anhydrase inhibitors. Bioorg Med Chem Lett 20:3467\u20133474","journal-title":"Bioorg Med Chem Lett"},{"key":"17_CR15","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.2174\/138161210793429797","volume":"16","author":"CT Supuran","year":"2010","unstructured":"Supuran CT (2010) Carbonic anhydrase inhibition\/activation: trip of a scientist around the world in the search of novel chemotypes and drug targets. Curr Pharm Des 16:3233\u20133245","journal-title":"Curr Pharm Des"},{"key":"17_CR16","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/med.10025","volume":"23","author":"CT Supuran","year":"2003","unstructured":"Supuran CT, Scozzafava A, Casini A (2003) Carbonic anhydrase inhibitors. Med Res Rev 23:146\u2013189","journal-title":"Med Res Rev"},{"key":"17_CR17","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1152\/physrev.1967.47.4.595","volume":"47","author":"TH Maren","year":"1967","unstructured":"Maren TH (1967) Carbonic anhydrase: chemistry, physiology and inhibition. Physiol Rev 47:595\u2013781","journal-title":"Physiol Rev"},{"key":"17_CR18","doi-asserted-by":"publisher","first-page":"4893","DOI":"10.1021\/ja01167a012","volume":"72","author":"WH Miller","year":"1950","unstructured":"Miller WH, Dessert AM, Roblin RO Jr (1950) Heterocyclic sulfonamides as carbonic anhydrase inhibitors. J Am Chem Soc 72:4893\u20134896","journal-title":"J Am Chem Soc"},{"key":"17_CR19","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4324\/9780203475300","volume-title":"Carbonic anhydrase \u2013 its inhibitors and activators","author":"CT Supuran","year":"2004","unstructured":"Supuran CT, Scozzafava A, Casini A (2004) Development of sulfonamide carbonic anhydrase inhibitors (CAIs). In: Supuran CT, Scozzafava A, Conway J (eds) Carbonic anhydrase \u2013 its inhibitors and activators. CRC Press, Boca Raton, pp 67\u2013147"},{"key":"17_CR20","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1136\/jmg.40.4.257","volume":"40","author":"SY Liao","year":"2003","unstructured":"Liao SY, Ivanov S, Ivanova A, Ghosh S, Cote MA, Keefe K, Coca-Prados M, Stanbridge EJ, Lerman MI (2003) Expression of cell surface transmembrane carbonic anhydrase genes CA9 and CA12 in the human eye: overexpression of CA12 (CAXII) in glaucoma. J Med Genet 40:257\u2013261","journal-title":"J Med Genet"},{"key":"17_CR21","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/0014-4835(83)90041-6","volume":"36","author":"TH Maren","year":"1983","unstructured":"Maren TH, Jankowska L, Sanyal G, Edelhauser HF (1983) The transcorneal permeability of sulfonamide carbonic anhydrase innhibitors and their effect on aqueous humor secretion. Exp Eye Res 36:457\u2013480","journal-title":"Exp Eye Res"},{"key":"17_CR22","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S1350-9462(99)00006-3","volume":"19","author":"MF Sugrue","year":"2000","unstructured":"Sugrue MF (2000) Pharmacological and ocular hypotensive properties of topical carbonic anhydrase inhibitors. Prog Ret Eye Res 19:87\u2013112","journal-title":"Prog Ret Eye Res"},{"key":"17_CR23","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1001\/archopht.1997.01100150047008","volume":"115","author":"TL Maus","year":"1997","unstructured":"Maus TL, Larsson LI, McLaren JW, Brubaker RF (1997) Comparison of dorzolamide and acetazolamide as suppresors of aqueous humor flow in humans. Arch Ophthalmol 115:45\u201349","journal-title":"Arch Ophthalmol"},{"issue":"suppl 2","key":"17_CR24","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0039-6257(99)00110-1","volume":"44","author":"LH Silver","year":"2000","unstructured":"Silver LH (2000) Dose\u2013response evaluation of the ocular hypotensive effect of brinzolamide ophthalmic suspension (Azopt). Brinzolamide dose\u2013response study group. Surv Ophthalmol 44(suppl 2):147\u2013153","journal-title":"Surv Ophthalmol"},{"key":"17_CR25","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.1600-0536.1998.tb05905.x","volume":"39","author":"K Aalto-Korte","year":"1998","unstructured":"Aalto-Korte K (1998) Contact allergy to dorzolamide eyedrops. Contact Dermatitis 39:206","journal-title":"Contact Dermatitis"},{"key":"17_CR26","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1001\/archopht.117.8.1087","volume":"117","author":"J Carlsen","year":"1999","unstructured":"Carlsen J, Durcan J, Swartz M, Crandall A (1999) Nephrolithiasis with dorzolamide. Arch Ophthalmol 117:1087\u20131088","journal-title":"Arch Ophthalmol"},{"key":"17_CR27","first-page":"93","volume":"34","author":"GW Thoe Schwartzenberg","year":"1999","unstructured":"Thoe Schwartzenberg GW, Trop GE (1999) Anorexia, depression and dementia induced by dorzolamide eyedrops (Trusopt). Can J Ophthalmol 34:93\u201394","journal-title":"Can J Ophthalmol"},{"key":"17_CR28","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0002-9394(98)00438-3","volume":"127","author":"A Konowal","year":"1999","unstructured":"Konowal A, Morrison JC, Brown SV, Cooke DL, Maguire LJ, Verdier DV (1999) Irreversible corneal decompensation in patients treated with topical dorzolamide. Am J Ophthalmol 127:403\u2013406","journal-title":"Am J Ophthalmol"},{"key":"17_CR29","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1021\/jm9900523","volume":"42","author":"A Scozzafava","year":"1999","unstructured":"Scozzafava A, Menabuoni L, Mincione F, Briganti F, Mincione G, Supuran CT (1999) Carbonic anhydrase inhibitors: synthesis of water-soluble, topically effective intraocular pressure lowering aromatic\/heterocyclic sulfonamides containing cationic or anionic moieties: is the tail more important than the ring? J Med Chem 42:2641\u20132650","journal-title":"J Med Chem"},{"key":"17_CR30","doi-asserted-by":"publisher","first-page":"3690","DOI":"10.1021\/jm9901879","volume":"42","author":"A Scozzafava","year":"1999","unstructured":"Scozzafava A, Briganti F, Mincione G, Menabuoni L, Mincione F, Supuran CT (1999) Carbonic anhydrase inhibitors. Synthesis of water-soluble, amino acyl\/dipeptidyl sulfonamides possessing long lasting-intraocular pressure lowering properties via the topical route. J Med Chem 42:3690\u20133700","journal-title":"J Med Chem"},{"key":"17_CR31","doi-asserted-by":"publisher","first-page":"4542","DOI":"10.1021\/jm000296j","volume":"43","author":"A Scozzafava","year":"2000","unstructured":"Scozzafava A, Menabuoni L, Mincione F, Briganti F, Mincione G, Supuran CT (2000) Carbonic anhydrase inhibitors: perfluoroalkyl\/aryl-substituted derivatives of aromatic\/heterocyclic sulfonamides as topical intraocular pressure lowering agents with prolonged duration of action. J Med Chem 43:4542\u20134551","journal-title":"J Med Chem"},{"key":"17_CR32","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1021\/jm0108202","volume":"45","author":"A Scozzafava","year":"2002","unstructured":"Scozzafava A, Menabuoni L, Mincione F, Supuran CT (2002) Carbonic anhydrase inhibitors. A general approach for the preparation of water soluble sulfonamides incorporating polyamino-polycarboxylate tails and of their metal complexes possessing long lasting, topical intraocular pressure lowering properties. J Med Chem 45:1466\u20131476","journal-title":"J Med Chem"},{"key":"17_CR33","doi-asserted-by":"publisher","first-page":"4421","DOI":"10.1021\/cr200176r","volume":"112","author":"V Alterio","year":"2012","unstructured":"Alterio V, Di Fiore A, D\u2019Ambrosio K, Supuran CT, De Simone G (2012) Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms? Chem Rev 112:4421\u20134468","journal-title":"Chem Rev"},{"key":"17_CR34","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.4155\/fmc.11.69","volume":"3","author":"CT Supuran","year":"2011","unstructured":"Supuran CT (2011) Carbonic anhydrase inhibitors and activators for novel therapeutic applications. Future Med Chem 3:1165\u20131180","journal-title":"Future Med Chem"},{"key":"17_CR35","doi-asserted-by":"publisher","first-page":"759","DOI":"10.3109\/14756366.2012.672983","volume":"27","author":"CT Supuran","year":"2012","unstructured":"Supuran CT (2012) Structure-based drug discovery of carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem 27:759\u2013772","journal-title":"J Enzyme Inhib Med Chem"},{"key":"17_CR36","doi-asserted-by":"publisher","first-page":"6565","DOI":"10.1016\/j.bmcl.2009.10.036","volume":"19","author":"RM Steele","year":"2009","unstructured":"Steele RM, Batugo MR, Benedini F, Biondi S, Borghi V, Carzaniga L, Impagnatiello F, Miglietta D, Chong WK, Rajapakse R, Cecchi A, Temperini C, Supuran CT (2009) Nitric oxide-donating carbonic anhydrase inhibitors for the treatment of open-angle glaucoma. Bioorg Med Chem Lett 19:6565\u20136570","journal-title":"Bioorg Med Chem Lett"},{"key":"17_CR37","doi-asserted-by":"publisher","first-page":"3216","DOI":"10.1016\/j.bmcl.2011.04.046","volume":"21","author":"F Mincione","year":"2011","unstructured":"Mincione F, Benedini F, Biondi S, Cecchi A, Temperini C, Formicola G, Pacileo I, Scozzafava A, Masini E, Supuran CT (2011) Synthesis and crystallographic analysis of new sulfonamides incorporating NO-donating moieties with potent antiglaucoma action. Bioorg Med Chem Lett 21:3216\u20133221","journal-title":"Bioorg Med Chem Lett"},{"key":"17_CR38","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3109\/14756366.2011.597749","volume":"27","author":"F Fabrizi","year":"2012","unstructured":"Fabrizi F, Mincione F, Somma T, Scozzafava G, Galassi F, Masini E, Impagnatiello F, Supuran CT (2012) A new approach to antiglaucoma drugs: carbonic anhydrase inhibitors with or without NO donating moieties. Mechanism of action and preliminary pharmacology. J Enzyme Inhib Med Chem 27:138\u2013147","journal-title":"J Enzyme Inhib Med Chem"},{"key":"17_CR39","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.bmcl.2012.12.058","volume":"23","author":"DD Long","year":"2013","unstructured":"Long DD, Frieman B, Hegde SS, Hill CM, Jiang L, Kintz S, Marquess DG, Purkey H, Shaw JP, Steinfeld T, Wilson MS, Wrench K (2013) A Multivalent approach towards linked dual-pharmacology prostaglandin F receptor agonist\/carbonic anhydrase-II inhibitors for the treatment of glaucoma. Bioorg Med Chem Lett 23:939\u2013943","journal-title":"Bioorg Med Chem Lett"},{"key":"17_CR40","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1039\/c2cc16395k","volume":"48","author":"F Carta","year":"2012","unstructured":"Carta F, Aggarwal M, Maresca A, Scozzafava A, McKenna R, Supuran CT (2012) Dithiocarbamates: a new class of carbonic anhydrase inhibitors. Crystallographic and kinetic investigations. Chem Commun (Cambridge) 48:1868\u20131870","journal-title":"Chem Commun (Cambridge)"},{"key":"17_CR41","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1021\/jm300031j","volume":"55","author":"F Carta","year":"2012","unstructured":"Carta F, Aggarwal M, Maresca A, Scozzafava A, McKenna R, Masini E, Supuran CT (2012) Dithiocarbamates strongly inhibit carbonic anhydrases and show antiglaucoma action in vivo. J Med Chem 55:1721\u20131730","journal-title":"J Med Chem"},{"key":"17_CR42","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.bmcl.2011.12.033","volume":"22","author":"SM Monti","year":"2012","unstructured":"Monti SM, Maresca A, Viparelli F, Carta F, De Simone G, M\u00fchlschlegel FA, Scozzafava A, Supuran CT (2012) Dithiocarbamates strongly inhibit the beta-class fungal carbonic anhydrases from Cryptococcus neoformans, Candida albicans and Candida glabrata. Bioorg Med Chem Lett 22:859\u2013862","journal-title":"Bioorg Med Chem Lett"},{"key":"17_CR43","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3109\/14756366.2011.641015","volume":"28","author":"A Maresca","year":"2013","unstructured":"Maresca A, Carta F, Vullo D, Supuran CT (2013) Dithiocarbamates strongly inhibit the beta-class carbonic anhydrases from Mycobacterium tuberculosis. J Enzyme Inhib Med Chem 28:407\u2013411","journal-title":"J Enzyme Inhib Med Chem"},{"key":"17_CR44","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.bmcl.2009.11.124","volume":"20","author":"C Temperini","year":"2010","unstructured":"Temperini C, Scozzafava A, Supuran CT (2010) Carbonic anhydrase inhibitors. X-Ray crystal studies of the carbonic anhydrase II \u2013 trithiocarbonate adduct \u2013 an inhibitor mimicking the sulfonamide and urea binding to the enzyme. Bioorg Med Chem Lett 20:474\u2013478","journal-title":"Bioorg Med Chem Lett"}],"container-title":["Subcellular Biochemistry","Carbonic Anhydrase: Mechanism, Regulation, Links to Disease, and Industrial Applications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-94-007-7359-2_17","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,19]],"date-time":"2023-02-19T17:32:53Z","timestamp":1676827973000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-94-007-7359-2_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,17]]},"ISBN":["9789400773585","9789400773592"],"references-count":44,"URL":"https:\/\/doi.org\/10.1007\/978-94-007-7359-2_17","relation":{},"ISSN":["0306-0225"],"issn-type":[{"value":"0306-0225","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9,17]]},"assertion":[{"value":"17 September 2013","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}